Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, Into which pharmerging market — aside from China and India — is your company most interested in expanding?

Brazil 46%
Turkey 4%
Russia 18%
Indonesia 4%
Argentina 7%
South Africa 4%
Other 17%

Talk to us:
jupton@advanstar.com

Advertise with us: mgoodrich@advanstar.com

14 August, 2012
In this Issue
Is the Term 'Strategic Partnership' An Oxymoron?
Andrew Parrett argues that strategic partnerships are neither strategic nor are they partnerships. And they don't add value to clinical trial outsourcing. Read more...
Bristol-Myers Squibb's Summertime Blues
The sun was shining, savoury scents were floating out from the grill, the lemonade was mixed and the table was set. But then dark clouds blew in and settled overhead — and Bristol-Myers Squibb's (BMS) picnic got rained out this summer. More...
Japanese Pharma Makes a Comeback
After a series of government reforms that are appealing to both domestic and foreign players, the Japanese pharmaceutical market is making a comeback, writes Jan Wan. More...
Read the August Pharm Exec Global Digest
The new issue — featuring patients on pricing, pharma’s rise in the social media stakes and how to build effectiveness into your sales force alignment — is available to read here. More...
Also in this issue…
PhRMA Research Awards Focus on Alzheimer's
Generics Help Hold the Line on Healthcare Costs
Upcoming Pharma Events

Product Profile
Sciformix

Sciformix is a functional service provider with core focus on scientific information and content generation. Our pool of highly qualified and trained Medical Writers and medical experts, with experience across diverse therapy areas, prepare customized responses to medical queries with short turnaround times and provide real-time support to marketing.
Read more